What Autoimmune Disease Causes Tinnitus?

Several autoimmune diseases can cause tinnitus, but the condition most directly associated with it is autoimmune inner ear disease (AIED), a rare disorder in which the immune system attacks structures of the inner ear. Tinnitus appears in roughly a quarter to half of AIED cases, alongside progressive hearing loss that typically affects both ears. Beyond AIED, a number of systemic autoimmune conditions, from lupus to rheumatoid arthritis, can produce tinnitus as part of their broader damage to the body.

Autoimmune Inner Ear Disease, the Primary Culprit

AIED is the autoimmune condition most closely linked to tinnitus because it directly targets the ear. First described as a distinct diagnosis in 1979, AIED is defined by progressive sensorineural hearing loss in both ears, driven by a misdirected immune response against inner ear tissue. The hearing loss tends to develop over weeks to months and is usually asymmetric, meaning one ear worsens faster than the other. In about 25–50% of cases, patients also experience tinnitus and a sensation of ear fullness.¹ Some patients also develop vestibular problems like vertigo.²

AIED is rare enough that many clinicians go years without seeing a textbook case, which makes it easy to miss. The hearing loss and tinnitus can look a lot like Ménière’s disease or age-related hearing changes, especially early on. One distinguishing feature is that AIED hearing loss tends to respond to corticosteroids, and in fact a positive response to steroids is often used to confirm the diagnosis when lab tests are inconclusive.³

How Autoimmune Inflammation Damages the Inner Ear

To understand why so many autoimmune diseases can produce tinnitus, it helps to know what happens inside the ear when the immune system goes haywire. The inner ear contains a structure called the stria vascularis, a thin layer of tissue packed with tiny blood vessels that maintains the delicate chemical balance needed for hearing. When immune complexes, essentially clumps of antibodies and their targets, get deposited in these blood vessels, the vessel walls swell and narrow. Blood flow drops, and the resulting oxygen deficit damages the hair cells that convert sound waves into nerve signals.⁴

This immune complex deposition can also cause a buildup of fluid in the inner ear, a condition known as endolymphatic hydrops, which disrupts the outer hair cells responsible for fine-tuning what you hear.⁵ When these hair cells are damaged or the chemical environment around them shifts, the auditory nerve can start sending abnormal signals to the brain, and you perceive those signals as tinnitus.

Researchers have also identified specific proteins that seem to play a role. One is heat shock protein 70 (HSP70), a stress-response molecule. In animal models, immune activation in the inner ear dramatically increased HSP70 levels in the cochlea, and some of those animals developed measurable hearing loss.⁶ The immune system may attack the ear’s own HSP70 through a process called molecular mimicry, where the protein resembles something foreign closely enough to draw friendly fire.²

Systemic Lupus Erythematosus

Lupus (SLE) is one of the systemic autoimmune diseases most studied for its effects on hearing. Lupus can cause hearing and balance problems through two distinct routes: direct immune-mediated damage to the inner ear, and ototoxicity from some of the drugs used to treat it.⁷ On the disease side, the same vasculitis mechanism described above applies. Immune complexes deposit in the auditory artery, reducing its diameter and choking off blood flow to the cochlea. The stria vascularis atrophies, and the hair cells and spiral ganglion neurons downstream suffer oxygen-deprived damage.⁴ Tinnitus in lupus patients often accompanies sensorineural hearing loss and can fluctuate alongside disease flares.

The drug angle is worth knowing about too. High-dose aspirin and certain antimalarials used in lupus treatment have known ototoxic effects, which means that not every case of tinnitus in a lupus patient is directly autoimmune. A clinician needs to sort out whether the ear symptoms are from the disease or its treatment, because the response would be very different.

Rheumatoid Arthritis

Rheumatoid arthritis (RA) is primarily known for attacking joints, but it can affect the ear in multiple ways. RA-related autoimmune inner ear disease can present as tinnitus, conductive hearing loss, sensorineural hearing loss, or a mix of these, though sensorineural hearing loss is the most common pattern.⁸ Compared to people without RA, patients with the condition have measurably higher hearing thresholds at most tested frequencies.⁹

RA can also affect the tiny joints in the middle ear, particularly the joint between the incus and stapes bones. When inflammation stiffens or erodes these joints, the result is conductive hearing loss on top of whatever inner ear damage has already occurred. This combination of middle and inner ear involvement makes RA-related hearing problems somewhat distinctive among autoimmune diseases. Tinnitus can arise from either the sensorineural or the conductive component.

Sjögren’s Syndrome

Sjögren’s syndrome is best known for causing dry eyes and dry mouth, but it can also target the ear. Research has found an increased prevalence of hearing loss, tinnitus, and sudden deafness among Sjögren’s patients compared to the general population. The tinnitus in Sjögren’s may be caused by several different mechanisms, including temporomandibular joint disorders (which are common in the disease), conductive hearing loss, damage to the cochlea, or involvement of the central nervous system.¹⁰

That last point is interesting because it hints at a separate pathway for tinnitus. When cochlear signals to the brain are reduced because of inner ear damage, the central auditory pathways can become hyperactive in a compensatory way. Brain imaging studies have shown that this loss of normal input can disturb neural activity in the central auditory system, and that disturbance is thought to underlie the perception of phantom sounds.¹⁰ In other words, tinnitus may not always originate in the ear itself but can develop “upstream” in the brain once the ear’s output is compromised.

Neuroinflammation and the Central Tinnitus Pathway

The idea that tinnitus has a central nervous system component gets stronger support from research into neuroinflammation. Animal studies have found that after damage to the auditory system, immune cells in the brain called microglia become activated in the auditory cortex and cochlear nucleus. These activated microglia release inflammatory molecules, which in turn activate more microglia, creating a self-reinforcing feedback loop. The result is an imbalance between excitatory and inhibitory nerve signaling in the auditory pathway, and that imbalance may be perceived as tinnitus.¹¹

This matters for autoimmune disease because systemic inflammation does not stay neatly contained. Conditions like lupus, Sjögren’s, and especially multiple sclerosis involve chronic immune activation that can affect the brain. In MS, tinnitus can develop either from hearing loss or from demyelination in the central nervous system, even in patients whose hearing tests look normal.¹² That finding underscores how autoimmune tinnitus is not always an ear problem; sometimes it is a brain problem triggered by immune activity in the wrong place.

Less Common Autoimmune Conditions That Affect the Ear

Beyond the major diseases, several rarer autoimmune conditions can cause tinnitus. Each has its own quirks worth knowing about.

Granulomatosis with polyangiitis (GPA), formerly called Wegener’s granulomatosis, is a vasculitis that affects small and medium blood vessels throughout the body. When it involves the ear, it can cause hearing loss, tinnitus, and middle ear problems. The inner ear damage comes from vasculitis of the cochlear blood supply, where thickened vessel walls and tiny hemorrhages disrupt the ionic balance the cochlea needs to function.¹³ Early on, the hearing loss from GPA can sometimes be reversed with immunosuppressive treatment, because the initial damage stems from reduced potassium levels in the inner ear fluid rather than permanent hair cell death. Left untreated, though, the inflammation leads to irreversible destruction.¹⁴

Relapsing polychondritis (RP) attacks cartilage throughout the body, and the ear’s cartilaginous structures make it a frequent target. Inner ear symptoms like hearing loss, tinnitus, and vertigo develop in somewhere between 7% and 42% of RP patients, a wide range that reflects the difficulty of studying an uncommon disease.¹⁵ In one published case, a patient’s first symptoms were hearing difficulty and tinnitus in both ears, with the classic cartilage inflammation only appearing later, which made early diagnosis nearly impossible.¹⁶

Cogan syndrome is a rare autoimmune disease that combines eye inflammation with inner ear symptoms, including bilateral hearing loss, tinnitus, and vertigo. It can also involve systemic vasculitis.¹⁷ Because Cogan syndrome affects both the eyes and the ears at once, it tends to be recognized earlier than some of the other conditions on this list, though it remains exceedingly rare.

Hashimoto’s thyroiditis, the most common autoimmune thyroid disease, has also been linked to AIED. Case reports describe patients developing the classic fluctuating hearing loss and tinnitus pattern of AIED in the context of active thyroid autoimmunity, with up to half of those patients experiencing tinnitus and vertigo.¹⁸ Whether the thyroid autoimmunity triggers the inner ear attack or the two processes simply coexist in people prone to autoimmunity remains an open question.

Diagnosing Autoimmune Tinnitus

One of the hardest parts of autoimmune tinnitus is nailing down the diagnosis. There is no single blood test that says “your tinnitus is autoimmune.” The most studied biomarker is the Western blot test for antibodies against HSP70, which has decent specificity. When the test is positive, a trial of corticosteroids is strongly justified. The problem is that the test is not very sensitive, meaning plenty of patients who actually have AIED will test negative.¹⁹ A reasonable diagnostic workup also includes an erythrocyte sedimentation rate (ESR), which flags general inflammation, plus more targeted blood tests if a specific systemic autoimmune disease is suspected.

In practice, clinicians often rely on pattern recognition: bilateral, progressive hearing loss with tinnitus developing over weeks to months in someone with either a known autoimmune condition or markers of systemic inflammation. Imaging can help rule out other causes like an acoustic neuroma or MS lesion. But the most telling diagnostic step may be the steroid trial itself. If hearing improves substantially after a course of high-dose prednisone, that strongly supports an autoimmune cause.³

Treatment and Whether Tinnitus Can Improve

The first-line treatment for autoimmune inner ear disease has been high-dose corticosteroids since the condition was first described.³ Steroids calm the immune response in the inner ear and can reverse hearing loss and tinnitus if started early enough, before permanent hair cell damage sets in. The catch is that steroids have serious long-term side effects, so patients who respond initially often need a transition to steroid-sparing immunosuppressants for maintenance.

Biologic therapies represent a newer frontier. While the evidence base is still limited, open pilot studies of various biologic agents have shown improvements in hearing, tinnitus, ear fullness, and vertigo in some AIED patients, including those who had stopped responding to steroids.²⁰ Several medications used for AIED can alleviate tinnitus even when they do not fully restore hearing.²¹

For the systemic autoimmune diseases, treating the underlying condition often helps the ear symptoms too. In GPA, starting immunosuppressive therapy early can reverse the initial cochlear damage before it becomes permanent.¹⁴ In lupus, controlling disease activity reduces vasculitis throughout the body, including in the auditory artery. The common theme across all these conditions is that timing matters enormously. The sooner the immune attack on the ear is brought under control, the better the odds of recovering at least some hearing and quieting the tinnitus.

Cancer Immunotherapy and Autoimmune Ear Damage

An emerging and somewhat unexpected source of autoimmune tinnitus comes from cancer treatment. Immune checkpoint inhibitors (ICIs), drugs that unleash the immune system to fight cancer, can sometimes cause collateral autoimmune damage to the ear. In a case series of patients with metastatic melanoma and renal cell carcinoma treated with ICIs or T-cell therapy, hearing loss and tinnitus were the most common ear symptoms. The hearing loss was sensorineural and bilateral in the majority of cases, and the median time from starting treatment to developing symptoms was about three months.²²

The good news is that two out of three patients in one series who received steroid treatment had substantial improvements in hearing.²³ As immunotherapy becomes more widespread in oncology, this particular variety of autoimmune tinnitus is likely to become more commonly recognized. Patients on these therapies who develop new tinnitus or hearing changes should flag it promptly, because early steroid intervention appears to make a real difference.

When Tinnitus Is Not Autoimmune

Not every person with an autoimmune disease who develops tinnitus has autoimmune tinnitus. Tinnitus is extraordinarily common in the general population, affecting an estimated 10–15% of adults at some point. Noise exposure, age-related hearing loss, earwax buildup, medications, and jaw problems can all produce tinnitus that has nothing to do with immunity. For someone with lupus or RA, the presence of tinnitus does not automatically implicate their autoimmune condition.

A few clues point toward an autoimmune cause specifically. If tinnitus arrives alongside rapidly worsening hearing, especially in both ears, that pattern looks much more like AIED than like noise damage or aging. If tinnitus fluctuates in sync with autoimmune disease flares, that temporal relationship is hard to dismiss. And if the tinnitus responds to corticosteroids or immunosuppressive therapy, the immune system almost certainly played a role. On the other hand, stable tinnitus in a single ear with stable hearing thresholds is far more likely to have a non-autoimmune explanation, even in someone who has an autoimmune disease.

Drug ototoxicity also deserves scrutiny. Some medications used to manage autoimmune conditions, including certain antimalarials, high-dose aspirin, and loop diuretics, are known to cause tinnitus on their own.⁷ Sorting out whether the disease or its treatment is responsible changes what you do about it, so it is worth raising with your doctor rather than assuming one explanation or the other.

1
PubMed Central. Autoimmune inner ear disease (AIED): A diagnostic challenge
2
PubMed Central. Investigating the Process of Autoimmune Inner Ear Disease: Unveiling the Intricacies of Pathogenesis and Therapeutic Strategies
3
PubMed Central. Immunosuppressive therapy for autoimmune inner ear disease
4
PubMed Central. Systemic Lupus Erythematosus and hearing disorders: Literature review and meta-analysis of clinical and temporal bone findings
5
Exploration of Immunology. Decoding the impact of autoinflammatory/autoimmune diseases on inner ear harmony and hearing loss
6
PubMed. Expression of heat shock protein 70 in the cochlea in experimental autoimmune inner ear disease
7
PubMed. Auditory function in patients with systemic lupus erythematosus
8
PubMed Central. Sudden-Onset Sensorineural Hearing Loss and Tinnitus in a Patient With Rheumatoid Arthritis: A Case Report and Literature Review
9
PubMed Central. The Effect of Rheumatoid Arthritis on Middle and Inner Ear Functions
10
BMJ. Increased prevalence of hearing loss, tinnitus and sudden deafness among patients with Sjögren’s syndrome
11
IntechOpen. Evidence of a Neuroinflammatory Model of Tinnitus
12
The International Tinnitus Journal. Otolaryngologic Symptoms in Multiple Sclerosis: A Review
13
PubMed Central. Audiological Manifestations in Patients with Granulomatosis with Polyangiitis
14
PubMed Central. Granulomatosis with polyangiitis presenting as isolated ear involvement: a case series and literature review
15
Research in Vestibular Science. Acute Peripheral Vestibular Syndrome in Relapsing Polychondritis
16
PubMed. Relapsing polychondritis presented as inner ear involvement
17
PubMed. Cogan Syndrome: A Case Study and Review of the Literature
18
PubMed Central. Autoimmune inner ear disease secondary to Hashimoto’s thyroiditis: a case report
19
PubMed. Utility of laboratory testing in autoimmune inner ear disease
20
PubMed Central. Emerging options in immune-mediated hearing loss
21
PubMed. Use of biologics for treatment of autoimmune inner ear disease
22
Otolaryngologia Polska. Ototoxicity in Immune Checkpoint Inhibitors Therapy
23
PubMed Central. Audiovestibular Toxicity Secondary to Immunotherapy: Case Series and Literature Review